361 related articles for article (PubMed ID: 22640851)
21. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
22. Hyperosmolar agents and clearance of mucus in the diseased airway.
Daviskas E; Anderson SD
J Aerosol Med; 2006; 19(1):100-9. PubMed ID: 16551221
[TBL] [Abstract][Full Text] [Related]
23. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2002; (1):CD002996. PubMed ID: 11869647
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of not-with cystic fibrosis associated forms bronchiectasis (non-CF bronchiectasis)].
Rademacher J; Pletz MW; Welte T
Internist (Berl); 2010 Dec; 51(12):1510-5. PubMed ID: 21079905
[TBL] [Abstract][Full Text] [Related]
25. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
Koskela H; Purokivi M
Duodecim; 2011; 127(24):2653-9. PubMed ID: 22320108
[TBL] [Abstract][Full Text] [Related]
26. Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice.
Terlizzi V; Masi E; Francalanci M; Taccetti G; Innocenti D
Ital J Pediatr; 2021 Aug; 47(1):168. PubMed ID: 34362426
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.
Xie B; Liu P; Wu Q; Xiang W
Am J Emerg Med; 2020 Dec; 38(12):2713-2717. PubMed ID: 33046287
[TBL] [Abstract][Full Text] [Related]
28. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
[TBL] [Abstract][Full Text] [Related]
29. New treatment options for bronchiectasis.
Metersky ML
Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
[TBL] [Abstract][Full Text] [Related]
30. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
Anuradha KWDA; Gunathilaka PKG; Wickramasinghe VP
Pediatr Pulmonol; 2021 Feb; 56(2):509-515. PubMed ID: 33295693
[TBL] [Abstract][Full Text] [Related]
32. Mucolytics in cystic fibrosis.
Henke MO; Ratjen F
Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
[TBL] [Abstract][Full Text] [Related]
33. New therapeutic options for noncystic fibrosis bronchiectasis.
Yap VL; Metersky ML
Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.
Amaro R; Panagiotaraka M; Alcaraz V; Torres A
Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445
[TBL] [Abstract][Full Text] [Related]
35. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
[TBL] [Abstract][Full Text] [Related]
36. Mucoactive agents for adults with acute lung conditions: A systematic review.
Tarrant BJ; Maitre CL; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Heart Lung; 2019; 48(2):141-147. PubMed ID: 30409442
[TBL] [Abstract][Full Text] [Related]
37. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Young IH
Chest; 2001 Feb; 119(2):414-21. PubMed ID: 11171717
[TBL] [Abstract][Full Text] [Related]
38. Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.
Máiz L; Girón RM; Prats E; Clemente MG; Polverino E; Caño S; Cordovilla R; Dorca J; Peñalver C; Baranda F; Martínez-García MA
Ther Adv Respir Dis; 2018; 12():1753466618787385. PubMed ID: 30014774
[TBL] [Abstract][Full Text] [Related]
39. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
[TBL] [Abstract][Full Text] [Related]
40. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT
Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
